EDIT vs TSLA · rev $32.3M vs P/E 179, rev $94.83B
Editas Medicine Inc (EDIT) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
EDIT currently screens at market cap $375.2M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the EDIT and TSLA stock pages for the full models.
Not investment advice.